Genpharmasec promoter Rajesh Mirchumal Sadhwani acquired 50,00,000 equity shares in the open market on August 28, 2026. The transaction represents a 0.90% stake increase under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The acquisition was disclosed to BSE Limited and the company’s Board of Directors on August 31, 2026. Sadhwani, based in Dubai, executed the purchase through open market transactions, increasing his individual holding from 7,30,00,000 shares to 7,80,00,000 shares.

Promoter Group Holding

Sadhwani acts in concert with Sneha Sadhwani. While Sadhwani’s stake increased, Sneha Sadhwani’s holding remained unchanged at 9,30,01,000 shares (16.80%).

The combined promoter group holding now stands at 30.88% of the total voting capital. There were no changes in encumbrances, voting rights otherwise than by shares, or convertible securities associated with this transaction.

What the Numbers Show

The promoter group’s consolidated stake has crossed the 30% threshold, rising from 29.98% to 30.88%. This move consolidates control within the promoter circle without altering the relative weightage between the two persons acting in concert. With zero encumbrances reported on the acquired shares, the transaction reflects a clean addition to unpledged promoter holdings.

Genpharmasec will hold a board meeting on September 2, 2026, to approve its annual report and finalize logistics for its upcoming Annual General Meeting. The gathering aims to conclude statutory formalities for the fiscal year ended March 31, 2026.

The company notified BSE Limited on August 28, 2026, regarding the meeting scheduled at its registered office. The agenda focuses on administrative and compliance matters rather than financial results, which are typically disclosed separately.

Key Agenda Items

The Board of Directors will address several critical governance tasks during the session:

• Fixing the date, time, and mode for the 34th Annual General Meeting (AGM)
• Approving the draft notice and calendar of events for the AGM
• Determining the cut-off date for voting rights entitlement
• Setting commencement and closing dates for e-voting
• Approving the Directors Report for the year ended March 31, 2026
• Finalizing the Annual Report for Financial Year 2025-26
• Closing the share transfer books and register of members
• Appointing a scrutinizer for e-voting at the 34th AGM

Compliance Context

The intimation was issued in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sohan Chaturvedi, Whole-time Director and CFO, signed the disclosure document.

Investors should note that this meeting is procedural in nature. No financial performance metrics or strategic updates were included in the initial intimation.